| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6967bba8150e0b546153ebb0fbc0eec9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate |
2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db3798bda9c697a8bd3e81f1baaffd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_585205b5fd61e6bd9b02ad671c534a2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c82ed4ef778d187dd26b2e6eb34e56e |
| publicationDate |
2018-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108245506-A |
| titleOfInvention |
Use of arctigenin in the preparation of medicines for treating corneal ulcers |
| abstract |
The invention relates to the medical use of arctigenin, which belongs to the field of medicine. Specifically, the invention discloses the use of arctigenin in preparing medicine for treating corneal ulcer. Experiments have proved that arctigenin can significantly reduce the area of corneal ulcer and reduce the ulcer score. It has definite curative effect and low toxic and side effects in the treatment of corneal ulcer. Moreover, arctigenin can also be administered systemically in addition to the conventional local administration route in the treatment of corneal ulcer. Therefore, arctigenin has a good application prospect in the treatment of corneal ulcer. |
| priorityDate |
2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |